TABLE OF CONTENTS
|  | | | Volume 109, Issue 2 (297-528)
Published online 23 July 2013
|  | In this issue
 Editorial
Minireview
Clinical Studies
Translational Therapeutics
Molecular Diagnostics
Genetics and Genomics
Letter to the Editor
Also new today
 Advance online publication
| | | | | | Advertisement | | | | | | Editorial | Top | | Decreased FOXO3 within advanced human colon cancer: implications of tumour suppressor function S D Savkovic Br J Cancer 2013 109: 297-298; advance online publication, July 4, 2013; 10.1038/bjc.2013.354 Full Text | | Minireview | Top | | Functional and cancer genomics of ASXL family members M Katoh Br J Cancer 2013 109: 299-306; advance online publication, June 4, 2013; 10.1038/bjc.2013.281 Abstract | Full Text | | Clinical Studies | Top | | Paired related homoeobox 1, a new EMT inducer, is involved in metastasis and poor prognosis in colorectal cancer Y Takahashi, G Sawada, J Kurashige, R Uchi, T Matsumura, H Ueo, Y Takano, S Akiyoshi, H Eguchi, T Sudo, K Sugimachi, Y Doki, M Mori and K Mimori Br J Cancer 2013 109: 307-311; advance online publication, June 27, 2013; 10.1038/bjc.2013.339 Abstract | Full Text | | | | Limited role for surveillance PET–CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy C Y Cheah, M S Hofman, M Dickinson, A Wirth, D Westerman, S J Harrison, K Burbury, M Wolf, H Januszewicz, K Herbert, H M Prince, D A Carney, D S Ritchie, R J Hicks and J F Seymour Br J Cancer 2013 109: 312-317; advance online publication, June 27, 2013; 10.1038/bjc.2013.338 Abstract | Full Text | | | | Statin use in primary inflammatory breast cancer: a cohort study T M Brewer, H Masuda, D D Liu, Y Shen, P Liu, T Iwamoto, K Kai, C M Barnett, W A Woodward, J M Reuben, P Yang, G N Hortobagyi and N T Ueno Br J Cancer 2013 109: 318-324; advance online publication, July 2, 2013; 10.1038/bjc.2013.342 Abstract | Full Text | | | | Sarcopenia and change in body composition following maximal androgen suppression with abiraterone in men with castration-resistant prostate cancer C Pezaro, D Mukherji, N Tunariu, A M Cassidy, A Omlin, D Bianchini, G Seed, A H M Reid, D Olmos, J S de Bono and G Attard Br J Cancer 2013 109: 325-331; advance online publication, June 27, 2013; 10.1038/bjc.2013.340 Abstract | Full Text | | | | Development and validation of a prognostic model in patients with metastatic renal cell carcinoma treated with sunitinib: a European collaboration A Bamias, K Tzannis, B Beuselinck, S Oudard, B Escudier, D Diosynopoulos, K Papazisis, H Lang, P Wolter, E de Guillebon, K Stravodimos, M Chrisofos, G Fountzilas, R-T Elaidi, M A Dimopoulos and C Bamia Br J Cancer 2013 109: 332-341; advance online publication, June 27, 2013; 10.1038/bjc.2013.341 Abstract | Full Text | | Translational Therapeutics | Top | | Synergistic antitumour activity of sorafenib in combination with tetrandrine is mediated by reactive oxygen species (ROS)/Akt signaling J Wan, T Liu, L Mei, J Li, K Gong, C Yu and W Li Br J Cancer 2013 109: 342-350; advance online publication, June 27, 2013; 10.1038/bjc.2013.334 Abstract | Full Text | | | | A leukotriene B4 receptor-2 is associated with paclitaxel resistance in MCF-7/DOX breast cancer cells H Kim, G-S Park, J E Lee and J-H Kim Br J Cancer 2013 109: 351-359; advance online publication, June 25, 2013; 10.1038/bjc.2013.333 Abstract | Full Text | | | | NGR-TNF, a novel vascular-targeting agent, does not induce cytokine recruitment of proangiogenic bone marrow-derived cells P Di Matteo, C Hackl, C Jedeszko, B Valentinis, C Bordignon, C Traversari, R S Kerbel and G-P Rizzardi Br J Cancer 2013 109: 360-369; advance online publication, July 4, 2013; 10.1038/bjc.2013.347 Abstract | Full Text | | | | A specific expression profile of heat-shock proteins and glucose-regulated proteins is associated with response to neoadjuvant chemotherapy in oesophageal adenocarcinomas J Slotta-Huspenina, C Wolff, E Drecoll, M Feith, M Bettstetter, K Malinowsky, L Bauer, K Becker, K Ott, H Höfler, K-F Becker and R Langer Br J Cancer 2013 109: 370-378; advance online publication, July 9, 2013; 10.1038/bjc.2013.319 Abstract | Full Text | | Molecular Diagnostics | Top | | CD44 variant 9 expression in primary early gastric cancer as a predictive marker for recurrence K Hirata, H Suzuki, H Imaeda, J Matsuzaki, H Tsugawa, O Nagano, K Asakura, H Saya and T Hibi Br J Cancer 2013 109: 379-386; advance online publication, June 18, 2013; 10.1038/bjc.2013.314 Abstract | Full Text | | | | FOXO3 expression during colorectal cancer progression: biomarker potential reflects a tumour suppressor role M D Bullock, A Bruce, R Sreekumar, N Curtis, T Cheung, I Reading, J N Primrose, C Ottensmeier, G K Packham, G Thomas and A H Mirnezami Br J Cancer 2013 109: 387-394; advance online publication, July 4, 2013; 10.1038/bjc.2013.355 Abstract | Full Text | | | | A derived neutrophil to lymphocyte ratio predicts clinical outcome in stage II and III colon cancer patients G Absenger, J Szkandera, M Pichler, M Stotz, F Arminger, M Weissmueller, R Schaberl-Moser, H Samonigg, T Stojakovic and A Gerger Br J Cancer 2013 109: 395-400; advance online publication, July 2, 2013; 10.1038/bjc.2013.346 Abstract | Full Text | | | | Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer M Ishizuka, H Nagata, K Takagi, Y Iwasaki and K Kubota Br J Cancer 2013 109: 401-407; advance online publication, July 2, 2013; 10.1038/bjc.2013.350 Abstract | Full Text | | | | Methylation levels of LINE-1 in primary lesion and matched metastatic lesions of colorectal cancer A Murata, Y Baba, M Watanabe, H Shigaki, K Miyake, T Ishimoto, M Iwatsuki, S Iwagami, Y Sakamoto, Y Miyamoto, N Yoshida, K Nosho and H Baba Br J Cancer 2013 109: 408-415; advance online publication, June 13, 2013; 10.1038/bjc.2013.289 Abstract | Full Text | | | | Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer M Stotz, A Gerger, F Eisner, J Szkandera, H Loibner, A L Ress, P Kornprat, W A Zoughbi, F S Seggewies, C Lackner, T Stojakovic, H Samonigg, G Hoefler and M Pichler Br J Cancer 2013 109: 416-421; advance online publication, June 25, 2013; 10.1038/bjc.2013.332 Abstract | Full Text | | | | TNF-receptor-1 adaptor protein FAN mediates TNF-induced B16 melanoma motility and invasion A Boecke, A C Carstens, C D Neacsu, N Baschuk, D Haubert, H Kashkar, O Utermöhlen, C Pongratz and M Krönke Br J Cancer 2013 109: 422-432; advance online publication, May 14, 2013; 10.1038/bjc.2013.242 Abstract | Full Text | | | | Inducing apoptosis of cancer cells using small-molecule plant compounds that bind to GRP78 S Martin, H K Lamb, C Brady, B Lefkove, M Y Bonner, P Thompson, P E Lovat, J L Arbiser, A R Hawkins and C P F Redfern Br J Cancer 2013 109: 433-443; advance online publication, June 27, 2013; 10.1038/bjc.2013.325 Abstract | Full Text | | | | Diagnostic SOX10 gene signatures in salivary adenoid cystic and breast basal-like carcinomas S V Ivanov, A Panaccione, D Nonaka, M L Prasad, K L Boyd, B Brown, Y Guo, A Sewell and W G Yarbrough Br J Cancer 2013 109: 444-451; advance online publication, June 25, 2013; 10.1038/bjc.2013.326 Abstract | Full Text | | | | Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer J H Huh, T H Kim, K Kim, J-A Song, Y J Jung, J-Y Jeong, M J Lee, Y K Kim, D H Lee and H J An Br J Cancer 2013 109: 452-461; advance online publication, June 27, 2013; 10.1038/bjc.2013.305 Abstract | Full Text | | | | Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy S Bellone, R Tassi, M Betti, D English, E Cocco, S Gasparrini, I Bortolomai, J D Black, P Todeschini, C Romani, A Ravaggi, E Bignotti, E Bandiera, L Zanotti, S Pecorelli, L Ardighieri, M Falchetti, C Donzelli, E R Siegel, M Azodi, D-A Silasi, E Ratner, P E Schwartz, T J Rutherford and A D Santin Br J Cancer 2013 109: 462-471; advance online publication, June 27, 2013; 10.1038/bjc.2013.315 Abstract | Full Text | | | | Polypeptide N-acetylgalactosaminyl transferase 3 independently predicts high-grade tumours and poor prognosis in patients with renal cell carcinomas S Kitada, S Yamada, A Kuma, S Ouchi, T Tasaki, A Nabeshima, H Noguchi, K-Y Wang, S Shimajiri, R Nakano, H Izumi, K Kohno, T Matsumoto and Y Sasaguri Br J Cancer 2013 109: 472-481; advance online publication, June 25, 2013; 10.1038/bjc.2013.331 Abstract | Full Text | | | | Ron tyrosine kinase receptor synergises with EGFR to confer adverse features in head and neck squamous cell carcinoma J Keller, A S Nimnual, K R Shroyer, C Joy, I Ischenko, C S Chandler, L M Dong, M J Hayman and E L Chan Br J Cancer 2013 109: 482-492; advance online publication, June 25, 2013; 10.1038/bjc.2013.321 Abstract | Full Text | | Genetics and Genomics | Top | | Patient survival in uveal melanoma is not affected by oncogenic mutations in GNAQ and GNA11 A E Koopmans, J Vaarwater, D Paridaens, N C Naus, E Kilic and A de Klein Rotterdam Ocular Melanoma Study group Br J Cancer 2013 109: 493-496; advance online publication, June 18, 2013; 10.1038/bjc.2013.299 Abstract | Full Text | | | | TERT promoter mutations in ocular melanoma distinguish between conjunctival and uveal tumours K G Griewank, R Murali, B Schilling, S Scholz, A Sucker, M Song, D Süsskind, F Grabellus, L Zimmer, U Hillen, K-P Steuhl, D Schadendorf, H Westekemper and M Zeschnigk Br J Cancer 2013 109: 497-501; advance online publication, June 25, 2013; 10.1038/bjc.2013.312 Abstract | Full Text | | | | miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1 Y Iwagami, H Eguchi, H Nagano, H Akita, N Hama, H Wada, K Kawamoto, S Kobayashi, A Tomokuni, Y Tomimaru, M Mori and Y Doki Br J Cancer 2013 109: 502-511; advance online publication, June 25, 2013; 10.1038/bjc.2013.320 Abstract | Full Text | | | | Gene expression profiling identifies different sub-types of retinoblastoma G Kapatai, M-A Brundler, H Jenkinson, P Kearns, M Parulekar, A C Peet and C M McConville Br J Cancer 2013 109: 512-525; advance online publication, June 11, 2013; 10.1038/bjc.2013.283 Abstract | Full Text | | Letter to the Editor | Top | | Comment on ‘The efficacy and toxicity of gemcitabine, carboplatin and bevacizumab in metastatic breast cancer‘ D Kitchen, M O'Brien, B Hughes, I Gill, S Rumbles, P Ellis and J Stebbing Br J Cancer 2013 109: 526-528; advance online publication, June 11, 2013; 10.1038/bjc.2013.279 Full Text | | | | | | Advertisement | | | | | | Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2013 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved. |  | | |
| |
No comments:
Post a Comment